X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27014) 27014
Newspaper Article (1981) 1981
Newsletter (168) 168
Book Chapter (134) 134
Magazine Article (43) 43
Book / eBook (37) 37
Dissertation (8) 8
Publication (7) 7
Trade Publication Article (3) 3
Book Review (2) 2
Conference Proceeding (2) 2
Government Document (2) 2
Reference (2) 2
Journal / eJournal (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16289) 16289
gram-negative bacteria (12088) 12088
microbiology (10777) 10777
bacteria (8703) 8703
female (6763) 6763
infectious diseases (6745) 6745
male (6737) 6737
animals (6640) 6640
gram-negative bacterial infections - microbiology (6086) 6086
infections (5074) 5074
anti-bacterial agents - pharmacology (4921) 4921
microbial sensitivity tests (4465) 4465
antibiotics (4311) 4311
gram-negative bacteria - drug effects (4136) 4136
middle aged (4108) 4108
adult (3905) 3905
anti-bacterial agents - therapeutic use (3547) 3547
immunology (3526) 3526
research (3438) 3438
aged (3314) 3314
gram-negative bacteria - isolation & purification (3299) 3299
escherichia-coli (3176) 3176
research article (2994) 2994
pathogens (2874) 2874
health aspects (2835) 2835
gram-negative bacterial infections - drug therapy (2824) 2824
pharmacology & pharmacy (2767) 2767
bacterial infections (2750) 2750
drug resistance (2571) 2571
medicine (2503) 2503
infection (2455) 2455
proteins (2428) 2428
analysis (2344) 2344
e coli (2203) 2203
antimicrobial agents (2148) 2148
virulence (2082) 2082
pseudomonas-aeruginosa (2073) 2073
risk factors (2006) 2006
gram-positive bacteria - drug effects (1993) 1993
gram-negative bacterial infections - epidemiology (1949) 1949
multidisciplinary sciences (1923) 1923
epidemiology (1904) 1904
adolescent (1884) 1884
drug resistance, bacterial (1866) 1866
identification (1840) 1840
genes (1764) 1764
drug resistance in microorganisms (1755) 1755
science (1735) 1735
mice (1699) 1699
retrospective studies (1675) 1675
gram-negative bacterial infections - diagnosis (1671) 1671
resistance (1650) 1650
mortality (1642) 1642
bacteriology (1619) 1619
gram-negative bacterial infections - veterinary (1618) 1618
cross infection - microbiology (1596) 1596
biology (1568) 1568
bacterial proteins - genetics (1554) 1554
molecular sequence data (1553) 1553
child (1544) 1544
bacteremia (1486) 1486
drug resistance, multiple, bacterial (1477) 1477
aged, 80 and over (1471) 1471
gram-positive bacteria - isolation & purification (1469) 1469
veterinary sciences (1440) 1440
gene expression (1433) 1433
prevalence (1418) 1418
life sciences (1402) 1402
bacteremia - microbiology (1363) 1363
antimicrobial resistance (1340) 1340
physiological aspects (1333) 1333
bacterial proteins - metabolism (1331) 1331
nosocomial infections (1298) 1298
biochemistry & molecular biology (1288) 1288
hospitals (1280) 1280
pneumonia (1256) 1256
treatment outcome (1242) 1242
gram-negative bacilli (1238) 1238
genetic aspects (1228) 1228
pseudomonas aeruginosa (1208) 1208
child, preschool (1196) 1196
biotechnology & applied microbiology (1193) 1193
bacterial infections - microbiology (1191) 1191
gram-positive bacteria (1188) 1188
sepsis (1187) 1187
antibiotic resistance (1134) 1134
escherichia coli (1127) 1127
bacterial pathogens (1124) 1124
laboratories (1123) 1123
infant (1108) 1108
biofilms (1102) 1102
polymerase chain reaction (1100) 1100
microorganisms (1097) 1097
strains (1068) 1068
phylogeny (1064) 1064
prospective studies (1059) 1059
enterobacteriaceae (1025) 1025
studies (1025) 1025
genomes (1024) 1024
risk-factors (1017) 1017
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (17) 17
Online Resources - Online (3) 3
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28450) 28450
Spanish (392) 392
Russian (190) 190
Portuguese (185) 185
French (173) 173
Japanese (172) 172
Chinese (143) 143
German (126) 126
Polish (66) 66
Turkish (54) 54
Italian (43) 43
Dutch (40) 40
Romanian (24) 24
Norwegian (13) 13
Bulgarian (12) 12
Ukrainian (12) 12
Czech (11) 11
Danish (11) 11
Hungarian (8) 8
Korean (7) 7
Finnish (6) 6
Swedish (6) 6
Croatian (4) 4
Hebrew (4) 4
Arabic (2) 2
Icelandic (2) 2
Galician (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American journal of emergency medicine, ISSN 0735-6757, 2017, Volume 35, Issue 4, pp. 579 - 583
...) from gram-positive (GP) bloodstream infections and determining the relationship between PCT levels, infection sites, and pathogen types... 
Emergency | Positive blood culture | Procalcitonin | Bacterial species | Gram-positive bacteria | Sepsis | Gram-negative bacteria | Infection sites | DIAGNOSIS | MANAGEMENT | ANTIBIOTIC USE | GUIDELINES | MARKERS | CALCITONIN | EMERGENCY MEDICINE | SEPTIC SHOCK | SERUM PROCALCITONIN | RESPIRATORY-TRACT INFECTIONS | Enterococcus faecalis | Escherichia coli | Humans | Middle Aged | Escherichia coli Infections - blood | Male | Acinetobacter Infections - blood | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Endocarditis, Bacterial - blood | Staphylococcus haemolyticus | Burkholderia cepacia | Gram-Positive Bacterial Infections - microbiology | Aged, 80 and over | Bacteremia - blood | Endocarditis, Bacterial - microbiology | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Staphylococcal Infections - microbiology | Klebsiella Infections - blood | Burkholderia Infections - microbiology | Staphylococcal Infections - blood | Staphylococcus aureus | Acinetobacter Infections - microbiology | Pneumonia, Bacterial - blood | Calcitonin - blood | Emergency Service, Hospital | Intensive Care Units | Pneumonia, Bacterial - microbiology | Escherichia coli Infections - microbiology | Biomarkers - blood | Klebsiella Infections - microbiology | Gram-Positive Bacterial Infections - blood | Enterococcus faecium | Staphylococcus hominis | Acinetobacter baumannii | Urinary Tract Infections - blood | Staphylococcus epidermidis | Catheter-Related Infections - blood | Catheter-Related Infections - microbiology | Gram-Negative Bacterial Infections - blood | Aged | Burkholderia Infections - blood | Klebsiella pneumoniae | Bacteria | Health aspects | Medical research | Medical examination | Microbiology | Emergency medicine | Analysis | Endocarditis | Medicine, Experimental | Urinary tract infections | Blood | Lupus | Klebsiella | Pathogens | Multiple sclerosis | Intensive care | Pneumonia | Bacterial infections | Disease | Laboratories | Lung cancer | Medical instruments | Infections | Arthritis | Family medical history | Urinary tract | Patients | Microorganisms | Thyroid cancer | Biomarkers | Cutoffs | Diagnostic systems
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2015, Volume 61, Issue suppl 2, pp. S69 - S78
Skin and soft-tissue infections (SSTIs) are an important cause of morbidity and mortality among hospitalized patients and a major therapeutic challenge for clinicians... 
telavancin | necrotizing infections | skin infections | cellulitis | soft-tissue infections | UNITED-STATES | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | RISK-FACTORS | NECROTIZING FASCIITIS | CARE-ASSOCIATED INFECTIONS | MICROBIOLOGY | IMMUNOLOGY | COMPLICATED SKIN | STREPTOCOCCAL INFECTIONS | STAPHYLOCOCCUS-AUREUS INFECTIONS | SURGICAL SITE INFECTION | EPIDEMIOLOGY | Skin Diseases, Bacterial - microbiology | Humans | Skin Diseases, Bacterial - drug therapy | Oxazolidinones - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Gram-Positive Bacterial Infections - microbiology | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Gram-Negative Bacterial Infections - drug therapy | Clinical Trials as Topic | Soft Tissue Infections - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Daptomycin - pharmacology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Oxazolidinones - pharmacology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | North America - epidemiology | Aminoglycosides - pharmacology | Gram-Positive Bacterial Infections - drug therapy | Aminoglycosides - therapeutic use
Journal Article
The Journal of infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial stewardship oversight significantly... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes
Journal Article
Expert review of anti-infective therapy, ISSN 1744-8336, 2014, Volume 6, Issue 5, pp. 751 - 763
...Although the problem of antimicrobial resistance in bacterial infections has attracted much attention, the magnitude of its impact on clinical and economic... 
healthcare-associated infection | study design | antimicrobial resistance | economic analysis | outcome | Study design | Economic analysis | Healthcare-associated infection | Antimicrobial resistance | Outcome | VANCOMYCIN-RESISTANT | INFECTIOUS DISEASES | RISK-FACTORS | MICROBIOLOGY | STAPHYLOCOCCUS-AUREUS BACTEREMIA | LENGTH-OF-STAY | NOSOCOMIAL INFECTIONS | ACQUIRED METHICILLIN-RESISTANT | ACINETOBACTER-BAUMANNII | PSEUDOMONAS-AERUGINOSA | PHARMACOLOGY & PHARMACY | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | Anti-Bacterial Agents - economics | Gram-Positive Bacterial Infections - economics | Hospital Costs | Cross Infection - economics | Length of Stay - economics | Gram-Positive Bacteria - drug effects | Humans | Cross Infection - mortality | Gram-Positive Bacterial Infections - mortality | Drug Resistance, Bacterial | Gram-Negative Bacterial Infections - drug therapy | Cross Infection - drug therapy | Gram-Negative Bacterial Infections - economics | Gram-Negative Bacterial Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Cross Infection - microbiology | Gram-Positive Bacterial Infections - microbiology | Anti-Bacterial Agents - pharmacology | Gram-Positive Bacterial Infections - drug therapy | Gram-Negative Bacterial Infections - mortality | Economic aspects | Drug resistance in microorganisms | Research | Analysis | Medical care, Cost of
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 1, pp. e0210991 - e0210991
.... Patients with disease- or therapy-related immunodeficiency are especially at risk for fatal infections caused by MDRO... 
HIGH-RISK PATIENTS | IMPACT | THERAPY | RECOMMENDATIONS | NEUTROPENIA | MULTIDISCIPLINARY SCIENCES | HEMATOLOGICAL MALIGNANCIES | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | SOCIETY | ENTEROBACTERIACEAE | Prognosis | Bacterial Infections - etiology | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - complications | Leukemia, Myeloid, Acute - microbiology | Gram-Negative Bacterial Infections - microbiology | Opportunistic Infections - etiology | Young Adult | Drug Resistance, Multiple, Bacterial | Gram-Positive Bacterial Infections - microbiology | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Retrospective Studies | Staphylococcal Infections - microbiology | Bacterial Infections - microbiology | Intensive Care Units | Staphylococcal Infections - drug therapy | Bacterial Infections - drug therapy | Kaplan-Meier Estimate | Gram-Negative Bacterial Infections - drug therapy | Gram-Positive Bacterial Infections - etiology | Induction Chemotherapy - adverse effects | Opportunistic Infections - microbiology | Vancomycin-Resistant Enterococci - isolation & purification | Opportunistic Infections - drug therapy | Adolescent | Aged | Gram-Negative Bacterial Infections - etiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Gram-Positive Bacterial Infections - drug therapy | Staphylococcal Infections - etiology | Drug resistance in microorganisms | Chemotherapy | Usage | Cancer patients | Research | Health aspects | Microbial colonies | Cancer | C-reactive protein | Microbiology | Transplants & implants | Leukemia | Oncology | Drug resistance | Cancer therapies | Subgroups | Proteins | Ethics | CRE bacteria | Neutropenia | Bacterial infections | Hematology | Myeloid leukemia | Mortality | Multidrug resistance | Immunodeficiency | Health risks | Staphylococcus infections | Patients | Disease control | Fever | Medicine | Multidrug resistant organisms | Infectious diseases | Hospitals | Acute myeloid leukemia | Colonization | Index Medicus
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1744-7666, 2014, Volume 16, Issue 2, pp. 159 - 177
Journal Article
PloS one, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, p. e37281
.... Here we have developed an in vivo model of long-term bacterial biofilm infections in a pediatric totally implantable venous access port (TIVAP... 
ANTIBIOTIC-LOCK TECHNIQUE | CONTROLLED-TRIAL | DIAGNOSIS | THERAPY | BACTEREMIA | IN-VIVO | BIOLOGY | ACCESS SYSTEM | MICE | CANCER | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Medical innovations | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article
Journal Article